Position Statements and Comments

 

2010

Comments to AHRQ regarding their draft Technology Assessment, Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment (January 2010)

 

2009

 

AMP urges federal agencies to implement GINA - 11/09

Letter to HHS Office for Civil Rights to support amending HIPAA Privacy Rule to implement GINA - 11/13/09

AMP reiterates its position on gene patents, direct-to-consumer marketing of genetic testing, and genetic nondiscrimination to the Secretary’s Advisory Committee on Genetics, Health & Society (SACGHS) on October 8. - 10/13/09

Comments to NIST Roadmap: "Measurement Science and Measurement Standards to Support Innovation in Healthcare - 9/09

Comments to CLIAC regarding ensuring laboratory testing quality during a public health emergency: AMP labs during the Spring 2009 H1N1 outbreak
- 9/2/09

AMP Principles for Health Care Reform

AMP priorities for Comparative Effectiveness Research (CER) - 6/09

AMP comments to the SACGHS - 6/09

AMP comments to the SACGHS draft report on gene patents - 5/15/09

AMP responds to Genentech Citizen Petition - 4/23/09

AMP recommends to the IOM priorities for Stimulus Bill spending on comparative effectiveness research (CER) - 3/09

 

2008

Gene Patents and the Exclusive Licensing of Genetic Discoveries - 11/08

Suggestions to the SACGHS regarding New Priorities - 7/08

Verbal Comments to the SACGHS Regarding Oversight of Genetic Testing Draft Report - 2/08

 

2007 and Earlier

Comments to the SACGHS Task Force Draft Report Regarding Oversight of Genetic Testiing - 12/07
AMP Position regarding Direct Access Genetic Testing (Direct to Consumer Genetic Testing) - 6/07
Letter to Sen. Dodd endorsing the "Medical Education Affordability Act" - 3/07
Comments to the SACGHS - 3/07
Response to FDA regarding IVDMIA Draft Guidance document - 3/07
Response to FDA regarding ASR Draft Guidance document - 3/07
Comments to CLIAC regarding introducing a Genetics Specialty to the CLIA regulations - 2/07
Letter to the House supporting the Genetics Information Nondiscrimination Act (GINA) - 1/07
Letter to the Senate supporting the Genetics Information Nondiscrimination Act (GINA) - 1/07
Comments to the SACGHS - 11/06
Comments to the SACGHS regarding Gene Patents - 6/06
Comments to the SACGHS regarding proposed Large Population Study - 6/06
Comments to CMS regarding Medically Unbelievable Edits - 5/06
Comments to FDA regarding CFTR Guidance Document - 5/06
Comments to CME regarding Equivalent Quality Control - 5/06
LabCorp v. Metabolite brief - 12/05
Comments to FDA regarding drug safety information - 12/05
Comments to NHIC regarding the Oncotype DX Test - 8/05
Letter to Trailblazer regarding cytogenetics reimbursement - 8/05
AMP Response to SACGHS Draft Report link to document AMPComments. - 5/05
Letter to Secretary Leavitt Regarding Cytology Proficiency Testing - 5/05
AMP Letter of Support for S.306, the Genetic Nondiscrimination Act - 2/05
AMP Comments Regarding the NIH Proposed “Best Practices for the Licensing of Genomic Inventions.� - 1/05
AMP Response to the DHHS Secretary's Advisory Committee on Genetic Testing - 1/00